Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A 2-year, multicenter, randomized, double-blind, placebo-controlled trial (ALADIN II)
A tutorial on propensity score estimation for multiple treatments using generalized boosted models
GLP-1RAs enhance insulin sensitivity and lower fasting insulin levels
Unlike conventional full agonists, LY3502970 preferentially activates G-protein signaling while minimizing -arrestin recruitment, a property expected to enhance metabolic efficacy while reducing adverse gastrointestinal effects (146)
Our unique formula includes a blend of nature's finest ingredients like strawberry and blueberry extracts, aa berry, and more to create a guilt-free, skin-loving elixir